Blueprint Medicines Corporation BPMC
129.46 0.00 (+0.00%)
At closeJul 18, 2025, 4:00 PM EDT
129.46 Day range 129.46
52-week range unavailable
- YTD
- +48.43%
- 1 year
- +13.20%
BPMC revenue history
Revenue is income from the company’s ordinary business activities.
508,824,000 USD
FY 2024 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2024 | 2024-12-31 | 508,824,000 | 259,444,000 | 104.04% |
| FY 2023 | 2023-12-31 | 249,380,000 | 45,344,000 | 22.22% |
| FY 2022 | 2022-12-31 | 204,036,000 | 23,956,000 | 13.30% |
| FY 2021 | 2021-12-31 | 180,080,000 | -613,655,000 | -77.31% |
| FY 2020 | 2020-12-31 | 793,735,000 | 727,223,000 | 1093.37% |
| FY 2019 | 2019-12-31 | 66,512,000 | 21,991,000 | 49.39% |
| FY 2018 | 2018-12-31 | 44,521,000 | 23,095,000 | 107.79% |
| FY 2017 | 2017-12-31 | 21,426,000 | -6,346,000 | -22.85% |
| FY 2016 | 2016-12-31 | 27,772,000 | 16,372,000 | 143.61% |
| FY 2015 | 2015-12-31 | 11,400,000 | 11,400,000 | Not meaningful |
| FY 2014 | 2014-12-31 | 0 | 0 | Not meaningful |
| FY 2013 | 2013-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-05-09T14:27:24.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.